ITGB3 and nasopharyngeal carcinoma: ITGB3 promotes the expression of SLC7A11 by enhancing its stability and activating the MAPK/ERK/ATF4/Nrf2 signalling axis, which inhibits the ferroptosis of NPC cells and promotes their metastasis [127].